Forget the Headlines: Novo Nordisk's (NVO) 4.6% Dividend Yield Is the Real Story for Patient Investors
There are exciting headlines galore regarding Danish healthcare company Novo Nordisk (NYSE: NVO) : Image source: Getty Images. See? It's enough to make one itch to become a shareholder. The stock is well worth considering for your portfolio. But look beyond the headlines, and you'll see another compelling reason to invest in Novo Nordisk: its dividend. The payout recently yielded a fat 4.6% (and when you add in the effect of share repurchases, the total shareholder yield comes in at about 5.5%). For comparison, the S&P 500 index of America's 500 largest companies recently yielded a mere 1%. Continue reading